Johannes Routila
MD, PhD
johannes.routila@utu.fi |
head and neck cancer; radioresistance; biomarkers; audiology; vestibulology; neuro-otology
Dissertation focused on the use of biomarkers in head and neck cancer therapy selection with special focus on radio- and chemoradiosensitivity associated stemness-related biomarkers.
In addition, I have research interests covering the fields of audiology and neuro-otology.
- Prognostic role of histological depth of invasion in T1-2 oropharyngeal squamous cell carcinoma (2026)
- American Journal of Otolaryngology
- Added value of HPV-DNA in situ hybridization as an adjunct to p16 Immunohistochemistry in oropharyngeal squamous cell carcinoma (2025)
- Acta Oto-Laryngologica
- Diverse oncogenes use common mechanisms to drive growth of major forms of human cancer (2025)
- Science Advances
- Evaluation of Integrin Glycovariants as Biomarkers of Metastasis, Invasion, and Therapy Stratification in Head and Neck Squamous Cell Carcinoma (2025)
- Cancer Medicine
- Histological tumor necrosis predicts decreased survival after neoadjuvant chemotherapy in head and neck squamous cell carcinoma (2025)
- Oral Oncology
- LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer (2025)
- Embo molecular medicine
- Assessment of targeted therapy opportunities in sinonasal cancers using patient-derived functional tumor models (2024)
- Translational Oncology
- Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma (2024)
- BMC Cancer
- Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer (2024)
- Cell
- Vestibular Evoked Myogenic Potential (VEMP) -mittaukset (2024) XLIV Valtakunnalliset audiologian päivät ja Teknisen audiologian iltapäivä Routila, Johannes



